<DOC>
	<DOCNO>NCT01340586</DOCNO>
	<brief_summary>The purpose study ass pharmacokinetics single oral dose 5 mg Apixaban subject normal renal function subject end stage renal disease ( ESRD ) maintain hemodialysis .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics Apixaban Subjects Hemodialysis</brief_title>
	<detailed_description>Primary Purpose : To provide clear understanding pharmacokinetics Apixaban subject ESRD determine effect hemodialysis Apixaban pharmacokinetics .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>The sign informed consent form . Subjects normal renal function classify base calculated creatinine clearance ( CLCr ) determine cockcroftgault calculation . Eligible subject ESRD maintain chronic stable hemodialysis . Any history abnormal bleeding coagulation disorder include first degree relative 50 year age . History significant head injury within last two year . Any gastrointestinal surgery could impact absorption study drug . Not expect continue hemodialysis treatment duration study . INR , PT , aPTT upper limit normal , unless agree upon investigator BMS medical monitor . History allergy Apixaban Factor Xa inhibitor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>PHARMACOKINETIC</keyword>
	<keyword>NOS</keyword>
</DOC>